- Home
- CGTX vs CYPH Comparison
CGTX vs CYPH Comparison
Compare CGTX & CYPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.14
N/A
Current Price
$0.55
Company Overview
Basic Information| Metric | CGTX | CYPH |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.5M | 51.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CGTX | CYPH |
|---|---|---|
| Price | $1.14 | $0.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.33 | N/A |
| AVG Volume (30 Days) | 624.0K | ★ 1.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $0.50 |
| 52 Week High | $3.83 | $3.70 |
Technical Indicators
Market Signals| Indicator | CGTX | CYPH |
|---|---|---|
| Relative Strength Index (RSI) | 52.08 | 41.24 |
| Support Level | $1.00 | $0.57 |
| Resistance Level | $1.19 | $0.77 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 80.56 | 31.93 |
Price Performance
Historical Comparison CGTX
CYPH
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About CYPH Cypherpunk Technologies Inc.
Cypherpunk Technologies Inc is a company developing novel therapies for patients with cancer and implementing a digital asset treasury plan focused on Zcash.